Amgen Inc P/B Ratio
Data as of August 04, 2026
P/B Ratio
23.58
Stock Price
$378.87
Book Value/Share
$16.07
Sector
Biotechnology
How It's Calculated
23.58 = $378.87 ÷ $16.07
What This Means
Amgen Inc's P/B ratio of 23.58 is above 6. Asset-light business models and unrecognized intangible assets can make book value a limited denominator; the multiple alone does not determine fair value.
About Amgen Inc
Amgen Inc (AMGN) operates in the Biotechnology sector, specifically in Biotechnology. With a market capitalization of about $207.87B, it ranks as a mega-cap stock — one of the largest publicly traded companies.
Shares recently traded near $378.87, within a 52-week range of $269.77 to $398.00 (-4.8% from the high, +40.4% from the low). Beta of 0.42 indicates relatively lower volatility versus the market.
Trailing profit margin is about 21.0%, signaling a solid profit margin for its industry.
Understanding This Metric
The price-to-book ratio compares market price to net asset value per share. For Amgen Inc, P/B is especially useful when earnings are volatile or temporarily depressed. In Biotechnology, asset-heavy business models often anchor closer to book value, while asset-light models may trade far above book.
Sector Comparison
Among Biotechnology names on our S&P 100 coverage, Amgen Inc's P/B ratio of 23.58 can be compared with peers such as GILD (7.17), REGN (2.57). Sector context helps interpretation, but each company's growth profile and balance sheet differ — use multiple metrics before drawing conclusions. View all Biotechnology stocks.
Key Takeaways
- AMGN is grouped in the Biotechnology sector for peer comparisons.
- Recent beta of 0.42 suggests lower-than-market price sensitivity.
- Trailing profit margin of 21.0% provides context for how much earnings support the headline multiple.
Related Tools & Guides
Explore calculators and guides connected to this metric, or view all metrics for AMGN.
Learn the full workflow
Compare PE with PB, PEG, EV/EBITDA, and market cap in one structured path.
Open the Stock Valuation hub →Other AMGN Metrics
Frequently Asked Questions
What does AMGN's price-to-book ratio indicate?
P/B compares share price to book value per share. Amgen Inc's P/B of 23.58 reflects how the market prices net assets — especially relevant for asset-heavy Biotechnology business models.
Is 23.58 above or below book value?
A P/B above 1.0 (23.58) means the market values AMGN above accounting book value — often due to brands, growth, or intangible assets.
How does P/B compare within Biotechnology?
Peer P/B levels in Biotechnology (e.g. GILD (7.17), REGN (2.57)) provide context; asset-light vs asset-heavy models differ materially.
Calculate the p/b ratio for any stock with our free calculator.
Open P/B Ratio Calculator →